Fabian Müller

2.5k total citations · 1 hit paper
58 papers, 2.0k citations indexed

About

Fabian Müller is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Fabian Müller has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 26 papers in Pediatrics, Perinatology and Child Health and 11 papers in Geriatrics and Gerontology. Recurrent topics in Fabian Müller's work include Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (24 papers) and Amino Acid Enzymes and Metabolism (10 papers). Fabian Müller is often cited by papers focused on Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (24 papers) and Amino Acid Enzymes and Metabolism (10 papers). Fabian Müller collaborates with scholars based in Germany, United States and Japan. Fabian Müller's co-authors include Martin F. Fromm, Jörg König, Renke Maas, Shingen Misaka, Maren Mieth, Hartmut Glaeser, Oliver Zolk, Peter Stopfer, Thomas Ebner and Thomas Bürkle and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Pharmacological Reviews.

In The Last Decade

Fabian Müller

54 papers receiving 2.0k citations

Hit Papers

Transporters and Drug-Drug Interactions: Important Determ... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
    2013 435 citations Jörg König, Fabian Müller et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabian Müller Germany 25 1.1k 726 517 300 209 58 2.0k
Ikuko Yano Japan 26 907 0.8× 819 1.1× 326 0.6× 399 1.3× 378 1.8× 170 2.4k
Karin Fattinger Switzerland 26 1.9k 1.7× 1.1k 1.6× 1.1k 2.2× 354 1.2× 284 1.4× 54 3.8k
Swati Nagar United States 24 816 0.7× 419 0.6× 906 1.8× 618 2.1× 288 1.4× 77 2.2k
George K. Dresser Canada 28 1.5k 1.3× 886 1.2× 1.4k 2.8× 518 1.7× 584 2.8× 59 3.9k
Christina L. Aquilante United States 26 425 0.4× 468 0.6× 829 1.6× 349 1.2× 210 1.0× 87 2.3k
Thomas D. Nolin United States 39 416 0.4× 736 1.0× 664 1.3× 819 2.7× 472 2.3× 135 4.3k
Phyllissa Schmiedlin‐Ren United States 19 1.3k 1.2× 739 1.0× 1.3k 2.4× 354 1.2× 242 1.2× 31 2.5k
Caroline Samer Switzerland 28 352 0.3× 440 0.6× 832 1.6× 295 1.0× 283 1.4× 107 2.5k
Robert A. Blouin United States 29 522 0.5× 478 0.7× 769 1.5× 345 1.1× 582 2.8× 119 2.8k
Sophie L. Stocker Australia 28 547 0.5× 448 0.6× 311 0.6× 509 1.7× 621 3.0× 115 2.6k

Countries citing papers authored by Fabian Müller

Since Specialization
Citations

This map shows the geographic impact of Fabian Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Müller more than expected).

Fields of papers citing papers by Fabian Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Müller. The network helps show where Fabian Müller may publish in the future.

Co-authorship network of co-authors of Fabian Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Müller. A scholar is included among the top collaborators of Fabian Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Müller. Fabian Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gessner, Arne, Jörg König, Markus R. Heinrich, et al.. (2024). New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. Clinical Pharmacology & Therapeutics. 117(1). 130–142. 5 indexed citations
3.
4.
Roessner, Philipp M., et al.. (2024). The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(2). 94–103. 2 indexed citations
5.
Gessner, Arne, Fabian Müller, Markus R. Heinrich, et al.. (2023). A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions. Clinical Pharmacology & Therapeutics. 114(5). 1058–1072. 13 indexed citations
6.
Müller, Fabian, Kathrin Hohl, Sascha Keller, et al.. (2023). N1‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid. Clinical Pharmacology & Therapeutics. 113(5). 1070–1079. 15 indexed citations
7.
Müller, Fabian, et al.. (2022). Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N1‐Methylnicotinamide: A PBPK Modeling Approach. Clinical Pharmacology & Therapeutics. 112(3). 687–698. 21 indexed citations
8.
Wiebe, Sabrina, Thomas Gießmann, Kathrin Hohl, et al.. (2020). Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. Clinical Pharmacokinetics. 59(12). 1627–1639. 45 indexed citations
9.
Hanke, Nina, Dominik Selzer, Naoki Ishiguro, et al.. (2020). A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals. Clinical Pharmacokinetics. 59(11). 1419–1431. 35 indexed citations
10.
Müller, Fabian, et al.. (2018). Biomarkers for In Vivo Assessment of Transporter Function. Pharmacological Reviews. 70(2). 246–277. 80 indexed citations
11.
Ono, Tomoyuki, Hideyuki Sato, Fabian Müller, et al.. (2018). Role of (−)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. European Journal of Clinical Pharmacology. 74(6). 775–783. 44 indexed citations
12.
Stopfer, Peter, Thomas Gießmann, Kathrin Hohl, et al.. (2017). Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail. European Journal of Drug Metabolism and Pharmacokinetics. 43(1). 69–80. 27 indexed citations
13.
Čečková, Martina, et al.. (2016). Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters. Xenobiotica. 47(1). 77–85. 31 indexed citations
14.
Knop, J., et al.. (2015). Renal tubular secretion of pramipexole. European Journal of Pharmaceutical Sciences. 79. 73–78. 14 indexed citations
15.
Misaka, Shingen, Junichi Yatabe, Fabian Müller, et al.. (2014). Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects. Clinical Pharmacology & Therapeutics. 95(4). 432–438. 107 indexed citations
16.
Müller, Fabian, Jörg König, Maren Mieth, et al.. (2014). Alanine-glyoxylate aminotransferase 2 (AGXT2) Polymorphisms Have Considerable Impact on Methylarginine and β-aminoisobutyrate Metabolism in Healthy Volunteers. PLoS ONE. 9(2). e88544–e88544. 31 indexed citations
17.
Dormann, Harald, Fabian Müller, Barbara Pfistermeister, et al.. (2013). Adverse Drug Events in Older Patients Admitted as an Emergency. Deutsches Ärzteblatt international. 110(13). 213–9. 68 indexed citations
18.
19.
Misaka, Shingen, Fabian Müller, & Martin F. Fromm. (2013). Clinical relevance of drug efflux pumps in the gut. Current Opinion in Pharmacology. 13(6). 847–852. 38 indexed citations
20.
Müller, Fabian, et al.. (2011). Influence of Non-Steroidal Anti-Inflammatory Drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-Mediated Drug Transport. Drug Metabolism and Disposition. 39(6). 1047–1053. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ikuko Yano Breakdown of academic impact, for papers by Karin Fattinger Breakdown of academic impact, for papers by Swati Nagar Breakdown of academic impact, for papers by George K. Dresser Breakdown of academic impact, for papers by Christina L. Aquilante Breakdown of academic impact, for papers by Thomas D. Nolin Breakdown of academic impact, for papers by Phyllissa Schmiedlin‐Ren Breakdown of academic impact, for papers by Caroline Samer Breakdown of academic impact, for papers by Robert A. Blouin Breakdown of academic impact, for papers by Sophie L. Stocker
Rankless by CCL
2026